Dr. Emily Schmied,, PhD

Claim this profile
Studies Diabetes
Studies Type 2 Diabetes
1 reported clinical trial
1 drug studied

Clinical Trials Emily Schmied,, PhD is currently running

Image of trial facility.

CGM Toolkit Training

for Diabetes

Study Overview: This interventional study aims to assess whether training healthcare professionals (HCPs) increases the number of continuous glucose monitor (CGM) prescriptions for patients with Type 2 Diabetes in a Federally Qualified Health Center serving a predominantly Hispanic/Latino population. Research Questions: Does HCP training enhance CGM prescription rates in a primary care setting? Does receiving a CGM prescription lead to improved Type 2 Diabetes control, as measured by Hemoglobin A1c levels? What barriers do patients face when prescribed and using CGMs? Given the significant impact of CGMs on diabetes management, this project seeks to improve CGM utilization among eligible patients through a focused intervention for HCPs and evaluate diabetes outcomes for those who do and do not receive a CGM. Methodology: HCPs and staff from three clinics within the same healthcare system will undergo a brief, in-person training on current clinical guidelines and insurance eligibility for CGMs. A booster session will follow about one month later to reinforce learning and address any prescribing challenges. Training efficacy will be evaluated by comparing CGM prescription rates before and after training using electronic health records. HCPs will complete pre- and post-training surveys to assess changes in knowledge, beliefs, and prescribing practices related to CGMs. Additionally, a small subset of prescribers will participate in interviews about their experiences with CGM prescriptions four months post-training. Patient Recruitment and Surveys: Patients with Type 2 Diabetes will be recruited for surveys at baseline, and at 3 and 6 months. These surveys will gather information on their diabetes management experience, levels of diabetes distress, and whether CGM discussions occurred with their primary care provider. Participants who received CGM prescriptions will share their experiences and any barriers encountered. A subset will also be invited for interviews to further explore their CGM experiences. Conclusion: This study seeks to fill a crucial gap in understanding how HCP training influences CGM prescription rates and the associated diabetes management outcomes, ultimately aiming to enhance diabetes care for a vulnerable population.

Recruiting

1 award

N/A

1 criteria

More about Emily Schmied,, PhD

Clinical Trial Related

1 year of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial

Treatments Emily Schmied,, PhD has experience with

  • CGM Toolkit Prescriber Training

Breakdown of trials Emily Schmied,, PhD has run

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Emily Schmied,, PhD specialize in?

Is Emily Schmied,, PhD currently recruiting for clinical trials?

Are there any treatments that Emily Schmied,, PhD has studied deeply?

What is the best way to schedule an appointment with Emily Schmied,, PhD?

Is there any support for travel costs?